Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1Completed 1Approved for marketing 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other 1

Conditions

Osteosarcoma 2Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Ifosfamide 6Leucovorin 5Doxorubicin 4Dexrazoxane 4Cisplatin 4Methotrexate 3Filgrastim 3Carboplatin 3mifamurtide 2glucarpidase 2Radiotherapy 2Neoadjuvant Therapy 2Mesna 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Cryosurgery 2Chemotherapy, Adjuvant 2temsirolimus 1sintilimab 1sargramostim 1saracatinib 1samarium Sm-153 lexidronam 1robatumumab 1pembrolizumab 1pegfilgrastim 1pazopanib 1omburtamab I-131 1niraparib 1lexatumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Osteosarcoma × glucarpidase × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

NCT00634322 2014-09-15

High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

BTG International Inc.

Phase 2 Terminated
7 enrolled 7 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡